Suppr超能文献

慢性诱导性荨麻疹中组胺释放的证据——系统评价。

Evidence for histamine release in chronic inducible urticaria - A systematic review.

机构信息

Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

出版信息

Front Immunol. 2022 Jul 28;13:901851. doi: 10.3389/fimmu.2022.901851. eCollection 2022.

Abstract

BACKGROUND

Chronic inducible urticaria (CIndU) constitutes a group of nine different CIndUs in which pruritic wheals and/or angioedema occur after exposure to specific and definite triggers. Histamine released from activated and degranulating skin mast cells is held to play a key role in the pathogenesis of CIndU, but evidence to support this has, as of yet, not been reviewed systematically or in detail. We aim to characterize the role and relevance of histamine in CIndU.

METHODS

We systematically searched 3 electronic databases (PubMed, Scopus, and Embase) for studies that reported increased serum or skin histamine concentration (direct evidence) or or histamine release (indirect evidence) following trigger exposure.

RESULTS

An initial total of 3,882 articles was narrowed down to 107 relevant studies of which 52 were in cold urticaria, 19 in cholinergic urticaria, 14 in heat urticaria, 10 in contact urticaria, 7 each in solar urticaria and vibratory angioedema, 4 each in symptomatic dermographism and aquagenic urticaria, and 3 in delayed pressure urticaria. The results of our review support that histamine has a key pathogenic role in the pathogenesis of all CIndUs, but it is not the sole mediator as evidenced by the often poor relationship between the level of histamine and severity of symptoms and the variable clinical efficacy of H-antihistamines.

CONCLUSIONS

Histamine released from skin mast cells is a key driver of the development of signs and symptoms and a promising therapeutic target in CIndU.

摘要

背景

慢性诱导性荨麻疹(CIndU)由九种不同的 CIndU 组成,在接触特定和明确的触发因素后,会出现瘙痒性风团和/或血管性水肿。从激活和脱颗粒的皮肤肥大细胞释放的组胺被认为在 CIndU 的发病机制中起关键作用,但迄今为止,尚无证据支持这一点。我们旨在描述组胺在 CIndU 中的作用和相关性。

方法

我们系统地在 3 个电子数据库(PubMed、Scopus 和 Embase)中搜索了报告在触发后血清或皮肤组胺浓度增加(直接证据)或组胺释放(间接证据)的研究。

结果

最初共检索到 3882 篇文章,最终缩小到 107 项相关研究,其中 52 项为寒冷性荨麻疹,19 项为胆碱能性荨麻疹,14 项为热性荨麻疹,10 项为接触性荨麻疹,7 项为光性荨麻疹和振动性血管性水肿,4 项为症状性皮肤划痕症和水源性荨麻疹,3 项为迟发性压力性荨麻疹。我们的综述结果支持组胺在所有 CIndU 的发病机制中具有关键的致病作用,但它不是唯一的介质,这可以从组胺水平与症状严重程度之间的关系往往不佳以及 H 抗组胺药的临床疗效可变得到证明。

结论

皮肤肥大细胞释放的组胺是导致 CIndU 体征和症状发展的关键驱动因素,是一种有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaff/9365951/e12ccd045073/fimmu-13-901851-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验